Aboriginal
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment (Wardman D, Khan N, el-Guebaly N) 355

accessibility
Counsellors in Primary Care: Benefits and Lessons Learned (Kates N, Crustolo A-M, Farrar S, Nikolaou L) 857

acute care
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay (Burge P, Ouellette-Kuntz H, Saeed H, McCreary B, Paquette D, Sim F) 243

acute care beds
Alternatives to Acute Hospital Psychiatric Care in East-End Montreal (Lesage AD, Bonsack C, Clerc D, Vanier C, Charron M, Sasseville M, Luyet A, Gélinas D) 49

ADHD
see attention-deficit hyperactivity disorder

ADHD subtypes
Neuropsychological Performance in DSM-IV ADHD Subtypes: An Exploratory Study With Untreated Adolescents (Schmitz M, Cadore L, Paczko M, Kipper L, Chaves M, Rohde LA, Moura C, Knijnik M) 863

admissions
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay (Burge P, Ouellette-Kuntz H, Saeed H, McCreary B, Paquette D, Sim F) 243

adolescents
Gender-Role Conflict and Suicidal Behaviour in Adolescent Girls (Pinhas L, Weaver H, Bryden P, Ghabbour N, Toner B) 473

Re: Atypical Antipsychotic Use in Treating Adolescents and Young Adults with Developmental Disabilities [letter] (Bradley EA, Lunsky Y, Berg JM, Brooks-Hill RW, O’Leary DA, Harman KE, Korossy M) 785

Neuropsychological Performance in DSM-IV ADHD Subtypes: An Exploratory Study With Untreated Adolescents (Schmitz M, Cadore L, Paczko M, Kipper L, Chaves M, Rohde LA, Moura C, Knijnik M) 863

adverse drug reactions
Re: Who Develops Severe or Fatal Adverse Drug Reactions to Selective Serotonin Reuptake Inhibitors? [letter] (Shaps HJ, Trigenis M, Barrueto F) 281

Reply: Who Develops Severe or Fatal Adverse Drug Reactions to Selective Serotonin Reuptake Inhibitors? The Authors Reply [letter] (Stewart DE, Dalfen A) 281

Hepatic Adverse Reactions Associated With Nefazodone (Stewart DE) 375

Catastrophic Reactions Induced by Tetrabenazine [letter] (Bruneau M-A, Lespérance P, Chouinard S) 683

affective disorder
Seasonal Affective Disorders: Relevance of Icelandic and Icelandic-Canadian Evidence to Etiologic Hypotheses (Axelsson J, Stefánsson JG, Magnússon A, Sigvaldason H, Karlsson MM) 153

age
Paternal Age as a Risk Factor [letter] (Raschka LB) 892

aged
Effective Use of Electroconvulsive Therapy in Late-Life Depression (Flint AJ, Gagnon N) 734

agoraphobia
Serum Cholesterol Level Comparison: Control Subjects, Anxiety Disorder Patients, and Obsessive–Compulsive Disorder Patients (Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M) 557

agranulocytosis
Relation Of Blood Counts During Clozapine Treatment to Serum Concentrations Of Clozapine and Nor-Clozapine (Oyewumi LK, Cernovsky ZZ, Freeman DJ, Streiner DL) 257

alcohol
Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study (Gross SR, Barrett SP, Shestowsky JS, Pihl RO) 546

alcohol abuse
Behavioural Therapy for the Treatment of Alcohol Abuse and Dependence [letter] (Sher L) 586

Alcoholism, Seasonal Depression, and Suicidal Behaviour [letter] (Sher L) 889

alternatives to hospitalization
Alternatives to Acute Hospital Psychiatric Care in East-End Montreal (Lesage AD, Bonsack C, Clerc D, Vanier C, Charron M, Sasseville M, Luyet A, Gélinas D) 49

Alzheimer’s disease
Cognitive Pharmacotherapy of Alzheimer’s Disease and Other Dementias (Herrmann N) 715

amphetamine
Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study (Gross SR, Barrett SP, Shestowsky JS, Pihl RO) 546

anorexia nervosa
Pharmacologic Treatment of Eating Disorders (Zhu AJ, Walsh BT) 227

Psychological Treatments for Anorexia Nervosa: A Review of Published Studies and Promising New Directions (Kaplan AS) 235

anticonvulsants
Managing Bipolar Disorder During Pregnancy: Weighing the Risks and Benefits (Viguera AC, Baldessarini RJ, Cohen LS, Nonacs R) 426

Lamotrigine Use in Geriatric Patients With Bipolar Depression (Robillard M, Conn DK) 767

antidepressants
“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder (Ghaemi SN, Ko JY, Goodwin FK) 125

Antidepressants and the Risk of Breast Cancer (Kurdyak PA, Gnam WH, Streiner DL) 966

antidepressive medications
Progress Against Major Depression in Canada (Patten SB) 775

antipsychotic
Testing for Antipsychotic-Induced Diabetes Mellitus [letter] (Kane BJ) 94

Antipsychotic Medication During Pregnancy and Lactation in Women With Schizophrenia: Evaluating the Risk (Patton SW, Misri S, Corral MR, Perry KF, Kuan AJ) 959

antipsychotic drugs
Are Leptin and Cytokines Involved in Body Weight Gain During Treatment With Antipsychotic Drugs? (Baptista T, Beaulieu S) 742

anxiety
Sleep Quality in Chronic Pain Patients (Sayar K, Arikan M, Yontem T) 844

anxiety disorders
Serum Cholesterol Level Comparison: Control Subjects, Anxiety Disorder Patients, and Obsessive–Compulsive Disorder Patients (Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M) 557

assessment
PTSD and the Experience of Pain: Research and Clinical Implications of Shared Vulnerability and Mutual Maintenance Models (Asmundson GJG, Coons MJ, Taylor S, Katz J) 930

attention-deficit hyperactivity disorder
Attention-Deficit Hyperactivity Disorder: Critical Appraisal of Extended Treatment Studies (Schachar R, Jadad AR, Gauld M, Boyle M, Booker L, Snider A, Kim M, Cunningham C) 337

Clinical Implications of a Link Between Fetal Alcohol Spectrum Disorder and Attention-Deficit Hyperactivity Disorder (O’Malley KD, Nanson J) 349

Neuropsychological Performance in DSM-IV ADHD Subtypes: An Exploratory Study With Untreated Adolescents (Schmitz M, Cadore L, Paczko M, Kipper L, Chaves M, Rohde LA, Moura C, Knijnik M) 863

Critical Appraisal of Extended Treatment Studies in Attention-Deficit Hyperactivity Disorder [letter] (Jerome L) 975

atypical antipsychotics
Atypical Antipsychotics: Mechanism of Action (Seeman P) 27

Atypical Antipsychotic Drugs and Glucose Dysregulation [letter] (Baptista T) 94

Re: Atypical Antipsychotic Use in Treating Adolescents and Young Adults with Developmental Disabilities [letter] (Bradley EA, Lunsky Y, Berg JM, Brooks-Hill RW, O’Leary DA, Harman KE, Korossy M) 785

Reply: Atypical Antipsychotic Use in Treating Adolescents and Young Adults With Developmental Disabilities [letter] (Friedlander R, Lazar S, Klancnik J) 785

Benefits of Switching From Typical to Atypical Antipsychotic Medications: A Longitudinal Study in a Community-Based Setting (Cook PE, Goldberg JO, Van Lieshout RJ) 870

Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia [letter] (Duggal HS) 887

atypical neuroleptics
Risperidone Decreases Craving and Relapses in Individuals With Schizophrenia and Cocaine Dependence (Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D) 671

Atypical Antipsychotics and Glycemia: A Case Report [letter] (Waldman JC, Yaren S) 686

autism
In Vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders (Stanley JA) 315

autocastration
Acute Onset of Schizophrenia Following Autocastration [letter] (Duggal HS, Jagadheesan K, Nizamie SH) 283

l’azithromycine
Délirium associé à l’azithromycine [letter] (Sirois F) 585

book review, sleep disorders
Stores G. A Clinical Guide to Sleep Disorders in Children and Adolescents. Mamelak M 578

book review, substance abuse
Philip B Heymann, William N Brownsberger, editors. Drug Addiction and Drug Policy: The Struggle to Control Dependence. el-Guebaly N 478

Connors GJ, Donovan DM, DiClemente CC. Substance Abuse Treatment and the Stages of Change: Selecting and Planning Interventions. Dongier M 575

book review, transcultural psychiatry Wen-Shing T. Handbook of Cultural Psychiatry. Engelsmann FF 379

book review, trauma
Graessner S, Gurris N, Pross C, editors. At the Side of Torture Survivors: Treating a Terrible Assault on Human Dignity. Cameron C 477

borderline personality disorder
Borderline Personality Disorder Comorbidity in Early- and Late-Onset Bipolar II Disorder [letter] (Benazzi F) 195

Voice Mail as a Transitional Object in the Treatment of Borderline Personality Disorder [letter] (Finch SJ) 974

brain
The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression (Bezchlibnyk Y, Young LT) 135

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging (Grady CL, Keightley ML) 327

breast cancer
Antidepressants and the Risk of Breast Cancer (Kurdyak PA, Gnam WH, Streiner DL) 966

bulimia nervosa
Pharmacologic Treatment of Eating Disorders (Zhu AJ, Walsh BT) 227

bupropion
Antidepressant Side Effects in Depression Patients Treated in A Naturalistic Setting: A Study of Bupropion, Moclobemide, Paroxetine, Sertraline, and Venlafaxine (Vanderkooy JD, Kennedy SH, Bagby RM) 174

Imaging Brain Chemistry and Function in Neuropsychiatric Disorders [editorial] (Williamson PC) 313

Bupropion-Methylphenidate Combination and Grand Mal Seizure [letter] (Ickowicz A) 790

Canada
Treatment-Seeking Rates and Associated Mediating Factors Among Individuals With Depression (Bristow K, Patten S) 660

Psychiatric Disorders and Use of Mental Health Services by Ontario Women (Frise S, Steingart A, Sloan M, Cotterchio M, Kreiger K) 849

cannabis
Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study (Gross SR, Barrett SP, Shestowsky JS, Pihl RO) 546

Capgras syndrome
Capgras Syndrome and Blindness: Against the Prosopagnosia Hypothesis [letter] (Dalgalarrondo P, Fujisawa G, Banzato CEM) 387

carbon dioxide test
Carbon Dioxide Test in Respiratory Panic Disorder Subtype [letter] (Nardi AE, Valença AM, Nascimento I, Zin WA, Versiani M) 685

Care Programme Approach
Rehabilitation in the United Kingdom: Research, Policy, and Practice. (Holloway F, Carson J, Davis S) 628

case–control study design
Antidepressants and the Risk of Breast Cancer (Kurdyak PA, Gnam WH, Streiner DL) 966

child psychiatry
Child Psychiatric Epidemiology and Canadian Public Policy-Making: The State of the Science and the Art of the Possible (Waddell C, Offord DR, Shepherd CA, Hua JM, McEwan K) 825

children
The National Survey of Mental Health and Well-Being in Australia: Impact on Policy (Henderson S) 819

cholesterol levels
Serum Cholesterol Level Comparison: Control Subjects, Anxiety Disorder Patients, and Obsessive–Compulsive Disorder Patients (Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M) 557

cholinesterase inhibitor
Cognitive Pharmacotherapy of Alzheimer’s Disease and Other Dementias (Herrmann N) 715

chronic depression
Breaking the Myths: New Treatment Approaches for Chronic Depression (Michalak EE, Lam RW) 635

chronic renal failure
Assessing and Managing Compulsive Scratching in Schizophrenia With Chronic Renal Failure [letter] (Strickland P, Rostron E, Haddad P, Deakin JFW, Dursun SM) 484

chronic pain
Sleep Quality in Chronic Pain Patients (Sayar K, Arikan M, Yontem T) 844

PTSD and the Experience of Pain: Research and Clinical Implications of Shared Vulnerability and Mutual Maintenance Models (Asmundson GJG, Coons MJ, Taylor S, Katz J) 930

clinical practice
The Psychiatrist and the Clinical Practice of Psychiatry in an Uncertain Environment: Looking Ahead [presidential address] (Albert J-M) 913

chronic stress
The Moderating Effects of Coping Strategies on Major Depression in the General Population (Wang J, Patten SB) 167

clinical decision making
Treatment Resistance in Anorexia Nervosa and the Pervasiveness of Ethics in Clinical Decision Making (MacDonald C) 267

clinical outcomes
Counsellors in Primary Care: Benefits and Lessons Learned (Kates N, Crustolo A-M, Farrar S, Nikolaou L) 857

clinical practice guidelines
Managing Schizophrenia During the Stable Phase: Is There Consensus Among Practice Guidelines? (Bhanji NH, Tempier R) 76

clinical studies
The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression (Bezchlibnyk Y, Young LT) 135

clozapine
Relation of Blood Counts During Clozapine Treatment to Serum Concentrations of Clozapine and Nor-Clozapine (Oyewumi LK, Cernovsky ZZ, Freeman DJ, Streiner DL) 257

A Case of Neuroleptic Malignant Syndrome With Clozapine and Risperidone [letter] (Beauchemin M-A, Millaud F, Nguyen KA) 886

Schizophrenia, Suicide and Blood Count During Treatment With Clozapine [letter] (Pompili M, Mancinelli I, Tatarelli R) 977

cocaine craving
Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence (Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D) 671

cognition
Cognitive Therapy For Schizophrenia: From Conceptualization to Intervention (Rector NA, Beck AT) 39

cognitive-behavioural therapy
Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia [letter] (Duggal HS) 887

cognitive enhancer
Cognitive Pharmacotherapy of Alzheimer’s Disease and Other Dementias (Herrmann N) 715

cognitive therapy
Cognitive Therapy For Schizophrenia: From Conceptualization to Intervention (Rector NA, Beck AT) 39

collaboration
Strategies of Collaboration Between General Practitioners and Psychiatrists: A Survey of Practitioners’ Opinions and Characteristics (Lucena RJM, Lesage A, Élie R, Lamontagne Y, Corbière M) 750

combination therapy
Breaking the Myths: New Treatment Approaches for Chronic Depression (Michalak EE, Lam RW) 635

comité d’experts
La traduction des questionnaires et des tests : techniques et problèmes (Massoubre C, Lang F, Jaeger B, Jullien M, Pellet J) 61

communication
Counsellors in Primary Care: Benefits and Lessons Learned (Kates N, Crustolo A-M, Farrar S, Nikolaou L) 857

community
Benefits of Switching From Typical to Atypical Antipsychotic Medications: A Longitudinal Study in a Community-Based Setting (Cook PE, Goldberg JO, Van Lieshout RJ) 870

C cont'd

comorbidity
Major Depression and Its Association With Long-Term Medical Conditions (Gagnon LM, Patten SB) 149

Borderline Personality Disorder Comorbidity in Early- and Late-Onset Bipolar II Disorder [letter] (Benazzi F) 195

Epidemiologic Studies of Trauma, Posttraumatic Stress Disorder, and Other Psychiatric Disorders (Breslau N) 923

comparative study
Seasonal Affective Disorders: Relevance of Icelandic and Icelandic-Canadian Evidence to Etiologic Hypotheses (Axelsson J, Stefánsson JG, Magnússon A, Sigvaldason H, Karlsson MM) 153

comparison
Managing Schizophrenia During the Stable Phase: Is There Consensus Among Practice Guidelines? (Bhanji NH, Tempier R) 76

confusion
A Follow-Up Study of Patients With DSM-IV Schizophreniform Disorder (Iancu I, Dannon PN, Ziv R, Lepkifker E) 56

continuation treatment
Effective Use of Electroconvulsive Therapy in Late-Life Depression (Flint AJ, Gagnon N) 734

continuous variables
Categorizing Continuous Variables [letter] (Adrade C) 886

controlled trials
Psychological Treatments for Anorexia Nervosa: A Review of Published Studies and Promising New Directions (Kaplan AS) 235

coping
The Moderating Effects of Coping Strategies on Major Depression in the General Population (Wang J, Patten SB) 167

counselling
Counsellors in Primary Care: Benefits and Lessons Learned (Kates N, Crustolo A-M, Farrar S, Nikolaou L) 857

CPGs
see clinical practice guidelines

criminal harassment
Occupational Effects of Stalking (Abrams KM, Robinson GE) 468

criminalization
Experiments in Change: Pretrial Diversion of Offenders With Mental Illness (Swaminath RS, Mendonca JD, Vidal C, Chapman P) 450

critical incidents
Posttraumatic Symptoms and Disability in Paramedics (Regehr C, Goldberg G, Glancy GD, Knott T) 953

cross-sectional studies
Major Depression and Its Association With Long-Term Medical Conditions (Gagnon LM, Patten SB) 149

cytokines
Are Leptin and Cytokines Involved in Body Weight Gain During Treatment With Antipsychotic Drugs? (Baptista T, Beaulieu S) 742

data
Breaking Up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data (Streiner DL) 262

day hospital
Alternatives to Acute Hospital Psychiatric Care in East-End Montreal (Lesage AD, Bonsack C, Clerc D, Vanier C, Charron M, Sasseville M, Luyet A, Gélinas D) 49

delirium
Probable Dementia With Lewy Bodies and Risperidone-Induced Delirium [letter] (Morikawa M, Kishimoto T) 976

délirium
Délirium associé à l’azithromycine [letter] (Sirois F) 585

delusions
Cognitive Therapy For Schizophrenia: From Conceptualization to Intervention (Rector NA, Beck AT) 39

dementia
Cognitive Pharmacotherapy of Alzheimer’s Disease and Other Dementias (Herrmann N) 715

dementia with Lewy bodies
Probable Dementia With Lewy Bodies and Risperidone-Induced Delirium [letter] (Morikawa M, Kishimoto T) 976

déontologie
Le code de déontologie de 1996 de l’AMC annoté pour les psychiatres [énoncé de principe] (Neilson G) Vol. 47(6). Insert.

Le devoir de protection [énoncé de principe] Chaimowitz G, Glancy G. Vol 47(7). Insert.

depressed affect
The Association of Depressed Affect and Stroke in Institutionalized Canadians [letter] (Patten SB, Ramasubbu R, Simpson JSA) 791

depression
Seasonal Affective Disorders: Relevance of Icelandic and Icelandic-Canadian Evidence to Etiologic Hypotheses (Axelsson J, Stefánsson JG, Magnússon A, Sigvaldason H, Karlsson MM) 153

DAD = DSM-IV 296.23 [letter] (McFarthing AM) 196

In Vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders (Stanley JA) 315

Evidence That Latitude is Directly Related to Variation in Suicide Rates (Davis GE, Lowell WE) 572

Depression in Multiple Sclerosis Associated With Interferon Beta-1a (Rebif) [letter] (Pandya R, Patten S) 686

Sleep Quality in Chronic Pain Patients (Sayar K, Arikan M, Yontem T) 844

Antidepressants and the Risk of Breast Cancer (Kurdyak PA, Gnam WH, Streiner DL) 966

depressive disorder epidemiology
Major Depression and Its Association With Long-Term Medical Conditions (Gagnon LM, Patten SB) 149

depressive disorders
Treatment-Seeking Rates and Associated Mediating Factors Among Individuals With Depression (Bristow K, Patten S) 660

Effective Use of Electroconvulsive Therapy in Late-Life Depression (Flint AJ, Gagnon N) 734

Progress Against Major Depression in Canada (Patten SB) 775

developmental disabilities
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay (Burge P, Ouellette-Kuntz H, Saeed H, McCreary B, Paquette D, Sim F) 243

Senior Residents in Psychiatry: Views on Training in Developmental Disabilities (Burge P, Ouellette-Kuntz H, McCreary B, Bradley E, Leichner P) 568

Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario (Bradley EA, Thompson A, Bryson SE) 652

Re: Atypical Antipsychotic Use in Treating Adolescents and Young Adults with Developmental Disabilities [letter] (Bradley EA, Lunsky Y, Berg JM, Brooks-Hill RW, O’Leary DA, Harman KE, Korossy M) 785

diabetes mellitus
Testing for Antipsychotic-Induced Diabetes Mellitus [letter] (Kane BJ) 94

D cont'd

diagnosis
“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder (Ghaemi SN, Ko JY, Goodwin FK) 125

DAD = DSM-IV 296.23 [letter] (McFarthing AM) 196

Re: Canadian and American Psychiatrists’ Attitudes Toward Dissociative Disorder Diagnoses [letter] (Ross CA) 282

Re: Canadian and American Psychiatrists’ Attitudes Toward Dissociative Disorder Diagnoses. The Authors Reply [letter] (Lalonde JK, Hudson JI, Pope, Jr, HG) 282

diagnostic concepts
Diagnostic Concepts and the Prevention of Schizophrenia [editorial] (Tsuang MT, Faraone SV) 515

dichotomizing
Breaking Up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data (Streiner DL) 262

disability
Posttraumatic Symptoms and Disability in Paramedics (Regehr C, Goldberg G, Glancy GD, Knott T) 953

dissociative disorder
Re: Canadian and American Psychiatrists’ Attitudes Toward Dissociative Disorder Diagnoses [letter] (Ross CA) 282

Re: Canadian and American Psychiatrists’ Attitudes Toward Dissociative Disorder Diagnoses. The Authors Reply [letter] (Lalonde JK, Hudson JI, Pope, Jr, HG) 282

diversion
Experiments In Change: Pretrial Diversion of Offenders With Mental Illness (Swaminath RS, Mendonca JD, Vidal C, Chapman P) 450

dopamine receptors
Atypical Antipsychotics: Mechanism of Action (Seeman P) 27

dual diagnosis
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay (Burge P, Ouellette-Kuntz H, Saeed H, McCreary B, Paquette D, Sim F) 243

Senior Residents in Psychiatry: Views on Training in Developmental Disabilities (Burge P, Ouellette-Kuntz H, McCreary B, Bradley E, Leichner P) 568

duty to protect
The Duty to Protect [position paper] Chaimowitz G, Glancy G Vol 47 (7). Insert.

E

ethics
Treatment Resistance in Anorexia Nervosa and the Pervasiveness of Ethics in Clinical Decision Making (MacDonald C) 267

Research Ethics and Forensic Psychiatry: A Comment on Regehr and Others [letter] (Quinsey VL, Rice ME, Harris GT) 384

Research Ethics and Forensic Psychiatry: Response [letter] (Regehr C, Edwardh M, Bradford J) 385

The 1996 CMA Code of Ethics Annotated for Psychiatrists [position paper] (Neilson G) Vol. 47(6). Insert.

The Duty to Protect [position paper] Chaimowitz G, Glancy G Vol 47 (7). Insert.

etiology
Female Sexual Disorders: Psychiatric Aspects (Segraves RT) 419

evidence-based psychiatry
Evidence-Based Psychiatry [letter] (Leighton AH) 384

Evidence-Based Psychiatry: Response [letter] (Dongier M, Lesage A, Grunberg F, Stip E) 384

extended treatment studies
Critical Appraisal of Extended Treatment Studies in Attention-Deficit Hyperactivity Disorder [letter] (Jerome L) 975

family history
Preliminary Assessment of Intrahemispheric QEEG Measures in Bipolar Mood Disorders (Oluboka OJ, Stewart SL, Sharma V, Mazmanian D, Persad E) 368

family physician
Counsellors in Primary Care: Benefits and Lessons Learned (Kates N, Crustolo A-M, Farrar S, Nikolaou L) 857

FASD
see fetal alcohol spectrum disorder

female
Gender-Role Conflict and Suicidal Behaviour in Adolescent Girls (Pinhas L, Weaver H, Bryden P, Ghabbour N, Toner B) 473

Fire Fetishism in a Female Arsonist? [letter] (Balachandra K, Swaminath S) 487

female orgasmic disorder
Sildenafil Citrate for Female Orgasmic Disorder [letter] (Gamble J, Menzies R) 486

female sexual dysfunction
Female Sexual Disorders: Psychiatric Aspects (Segraves RT) 419

fetal alcohol spectrum disorder
Clinical Implications of a Link Between Fetal Alcohol Spectrum Disorder and Attention-Deficit Hyperactivity Disorder (O’Malley KD, Nanson J) 349

fire fetishism
Fire Fetishism in a Female Arsonist? [letter] (Balachandra K, Swaminath S) 487

First Nations
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment (Wardman D, Khan N, el-Guebaly N) 355

Fitness Interview Test
Interrater Reliability of the Fitness Interview Test Across Four Professional Groups (Viljoen JL, Roesch R, Zapf PA) 945

fitness to stand trial
Interrater Reliability of the Fitness Interview Test Across Four Professional Groups (Viljoen JL, Roesch R, Zapf PA) 945

forensic assessment
Interrater Reliability of the Fitness Interview Test Across Four Professional Groups (Viljoen JL, Roesch R, Zapf PA) 945

forensic psychiatry
Research Ethics and Forensic Psychiatry: A Comment on Regehr and Others [letter] (Quinsey VL, Rice ME, Harris GT) 384

Research Ethics and Forensic Psychiatry: Response [letter] (Regehr C, Edwardh M, Bradford J) 385

frontal lobes
Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging (Grady CL, Keightley ML) 327

frontotemporal dysfunction
Association of QEEG Findings With Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction (Tot Ô, Özge A, Çömelekoglu Ü, Yazici K, Bal N) 538

functional dyspepsia
Functional Dyspepsia and Mirtazapine [letter] (Sang-Yeol L, Seung-Ho R, Suck-Che C) 582

gabapentin
Gabapentin Treatment of Impulsive-Aggressive Behaviour [letter] (Biancosino B, Facchi A, Marmai L, Grassi L) 483

Gabapentin-Induced Paradoxical Exacerbation of Psychosis in a Patient With Schizophrenia [letter] (Jablonowski K, Margolese HC, Guy Chouinard G) 975

galactorrhea
A Case of Paroxetine-Induced Galactorrhea [letter] (Davenport E, Velamoor R) 890

gender
Gender-Role Conflict and Suicidal Behaviour in Adolescent Girls (Pinhas L, Weaver H, Bryden P, Ghabbour N, Toner B) 473

gene expression
The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression (Bezchlibnyk Y, Young LT) 135

general practice
Brief Screening Tests for Dementia (Lorentz WJ, Scanlan JM, Borson S) 723

general practitioner
Strategies of Collaboration Between General Practitioners and Psychiatrists: A Survey of Practitioners’ Opinions and Characteristics (Lucena RJM, Lesage A, Élie R, Lamontagne Y, Corbière M) 750

general psychiatry
Mental Health Reform and Evolution of General Psychiatry In Ontario John (Swenson JR, Bradwejn J) 644

generalized anxiety disorder
Worry WARTS Have Generalized Anxiety Disorder [letter] (Coupland NJ) 197

genetics
Understanding Predisposition to Schizophrenia: Toward Intervention and Prevention (Tsuang MT, Stone WS, Faraone SV) 518

geriatric psychiatry
Canadian Geriatric Psychiatrists: Why Do They Do It? A Delphi Study (Lieff S, Clarke D) 250

Geriatric Psychiatry: Complex Challenges, Promising Treatments (Shulman KI) 713

gestion de cas
Réadaptation Psychiatrique en Milieu Francophone : Pratiques Actuelles, Défis Futurs (Tempier R, Favrod J) 621

glucose dysregulation
Atypical Antipsychotic Drugs and Glucose Dysregulation [letter] (Baptista T) 94

G cont'd

glycemia
Atypical Antipsychotics and Glycemia: A Case Report [letter] (Waldman JC, Yaren S) 686

good prognostic factors
A Follow-Up Study of Patients With DSM-IV Schizophreniform Disorder (Iancu I, Dannon PN, Ziv R, Lepkifker E) 56

GPF
see good prognostic factors

grand mal seizure
Bupropion-Methylphenidate Combination and Grand Mal Seizure [letter] (Ickowicz A) 790

growth curve analysis
The Case of the Missing Data: Methods of Dealing With Dropouts and Other Research Vagaries (Streiner DL) 68

hair loss
Olanzapine-Induced Hair Loss [letter] (Leung M, Wrixon K, Remick RA) 891

hallucinations
Cognitive Therapy For Schizophrenia: From Conceptualization to Intervention (Rector NA, Beck AT) 39

Musical Hallucinations During a Treatment With Benzodiazepine [letter] (Curtin F, Remund C) 789

health policy
The National Survey of Mental Health and Well-Being in Australia: Impact on Policy (Henderson S) 819

help seeking
Treatment-Seeking Rates and Associated Mediating Factors Among Individuals With Depression (Bristow K, Patten S) 660

hemispheric asymmetry
Association of QEEG Findings With Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction (Tot Ô, Özge A, Çömelekoglu Ü, Yazici K, Bal N) 538

hepatic adverse reactions
Hepatic Adverse Reactions Associated With Nefazodone (Stewart DE) 375

hippocampus
Proton Magnetic Resonance Spectroscopy of the Hippocampus and Occipital White Matter in PTSD: Preliminary Results (Villarreal G, Petropoulos H, Hamilton DA, Rowland LM, Horan WP, Griego JA, Moreshead M, Hart BL, Brooks WM) 666

homicide
Homicide in the Canadian Prairies: Elderly and Nonelderly Killings (Ahmed AG, Menzies RPD) 875

hospitalization
The Ward Changes Address: An Entire Hospital Department Moves to a Modern Building [letter] (Melamed Y, Elizur A) 485

hostility
Massive Weight Gain and Hostility Force Mirtazapine Stoppage [letter] (Abraham G) 582

5-HT receptors
Atypical Antipsychotics: Mechanism of Action (Seeman P) 27

immigrants
Suicide Among Immigrants to Canada From the Indian Subcontinent [letter] (Singh K) 487

impulsive-aggressive behaviour
Gabapentin Treatment of Impulsive-Aggressive Behaviour [letter] (Biancosino B, Facchi A, Marmai L, Grassi L) 483

imputation
The Case of the Missing Data: Methods of Dealing With Dropouts and Other Research Vagaries (Streiner DL) 68

infant development
Antipsychotic Medication During Pregnancy and Lactation in Women With Schizophrenia: Evaluating the Risk (Patton SW, Misri S, Corral MR, Perry KF, Kuan AJ) 959

in vivo
In Vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders (Stanley JA) 315

inappropriate use
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment (Wardman D, Khan N, el-Guebaly N) 355

incidence
Prevalence and Incidence Studies of Schizophrenic Disorders: A Systematic Review of the Literature (Goldner EM, Hsu L, Waraich P, Somers JM) 833

insulin
Are Leptin and Cytokines Involved in Body Weight Gain During Treatment With Antipsychotic Drugs? (Baptista T, Beaulieu S) 742

integrated mental health system
Mental Health Reform and Evolution of General Psychiatry In Ontario John (Swenson JR, Bradwejn J) 644

intellectual disability
Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario (Bradley EA, Thompson A, Bryson SE) 652

intensive home care
Alternatives to Acute Hospital Psychiatric Care in East-End Montreal (Lesage AD, Bonsack C, Clerc D, Vanier C, Charron M, Sasseville M, Luyet A, Gélinas D) 49

interferon
Depression in Multiple Sclerosis Associated With Interferon Beta-1a (Rebif) [letter] (Pandya R, Patten S) 686

intimidation
Perceptions of Intimidation in the Psychiatric Educational Environment in Edmonton, Alberta (Tibbo P, de Gara CJ, Blake TM, Steinberg C, Stonehocker B) 562

intravenous
Intravenous Valproate Treatment: Some Observations [letter] (Duggal HS) 96

Inventaire de Personnalité de Freiburg (FPI-R)
La traduction des questionnaires et des tests : techniques et problèmes (Massoubre C, Lang F, Jaeger B, Jullien M, Pellet J) 61

la pratique clinique
Le psychiatre et la pratique clinique de la psychiatrie dans un environment incertain : penser à l’avenir [Presidential address] (Albert J-M) 913

lactation
Antipsychotic Medication During Pregnancy and Lactation in Women With Schizophrenia: Evaluating the Risk (Patton SW, Misri S, Corral MR, Perry KF, Kuan AJ) 959

language
Re: Using Language in Psychiatry [letter] (Friedman EH) 583

Reply: Using Language in Psychiatry [letter] (Fine J) 583

last observation carried forward
The Case of the Missing Data: Methods of Dealing With Dropouts and Other Research Vagaries (Streiner DL) 68

latitude
The Impact of Latitude on the Prevalence of Seasonal Depression (Levitt AJ, Boyle MH) 361

Evidence That Latitude is Directly Related to Variation in Suicide Rates (Davis GE, Lowell WE) 572

Seasonal Affective Disorder: The Latitude Hypothesis Revisited [letter] (Michalak EE, Lam RW) 787

le partage des soins der santé mentale
Le partage des soins de santé mentale : une bibliographie et une vue d’ensemble (Craven MA, Bland R) 1S–104S

left hemisphere
Association of QEEG Findings With Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction (Tot Ô, Özge A, Çömelekoglu Ü, Yazici K, Bal N) 538

length of stay
Canadian Psychiatric Inpatient Religious Commitment: An Association With Mental Health (Baetz M, Larson DB, Marcoux G, Bowen R, Griffin R) 159

Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay (Burge P, Ouellette-Kuntz H, Saeed H, McCreary B, Paquette D, Sim F) 243

leptin
Are Leptin and Cytokines Involved in Body Weight Gain During Treatment With Antipsychotic Drugs? (Baptista T, Beaulieu S) 742

life events
The Moderating Effects of Coping Strategies on Major Depression in the General Population (Wang J, Patten SB) 167

L cont'd

life satisfaction
Canadian Psychiatric Inpatient Religious Commitment: An Association With Mental Health (Baetz M, Larson DB, Marcoux G, Bowen R, Griffin R) 159

light-dark cycles
Evidence That Latitude is Directly Related to Variation in Suicide Rates (Davis GE, Lowell WE) 572

limbic system
Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging (Grady CL, Keightley ML) 327

lithium
Managing Bipolar Disorder During Pregnancy: Weighing the Risks and Benefits (Viguera AC, Baldessarini RJ, Cohen LS, Nonacs R) 426

LOCF
see last observation carried forward

longitudinal
Benefits of Switching From Typical to Atypical Antipsychotic Medications: A Longitudinal Study in a Community-Based Setting (Cook PE, Goldberg JO, Van Lieshout RJ) 870

mental illness
An Analysis of Religion and Mental Illness [letter] (Satyam Patel S, Cabrera-Abreu C) 971

Reply: An Analysis of Religion and Mental Illness [letter] (Baetz M, Bowen R, Marcoux G, Griffin R, Larson DB) 971

Re: Canadian Psychiatric Inpatient Religious Commitment: An Association With Mental Health [letter] (Watters WW) 972

Reply: Canadian Psychiatric Inpatient Religious Commitment: An Association With Mental Health [letter] (Baetz M, Bowen R, Marcoux G, Griffin R, Larson DB) 972

mental retardation
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay (Burge P, Ouellette-Kuntz H, Saeed H, McCreary B, Paquette D, Sim F) 243

Senior Residents in Psychiatry: Views on Training in Developmental Disabilities (Burge P, Ouellette-Kuntz H, McCreary B, Bradley E, Leichner P) 568

Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario (Bradley EA, Thompson A, Bryson SE) 652

methodology
Preventing Schizophrenia and Psychotic Behaviour: Definitions and Methodological Issues (Faraone SV, Hendricks Brown C, Glatt SJ, Tsuang MT) 527

3,4-methylendioxymethamphetamine
Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study (Gross SR, Barrett SP, Shestowsky JS, Pihl RO) 546

methylphenidate
Bupropion-Methylphenidate Combination and Grand Mal Seizure [letter] (Ickowicz A) 790

mirtazapine
Massive Weight Gain and Hostility Force Mirtazapine Stoppage [letter] (Abraham G) 582

Functional Dyspepsia and Mirtazapine [letter] (Sang-Yeol L, Seung-Ho R, Suck-Che C) 582

missing data
The Case of the Missing Data: Methods of Dealing With Dropouts and Other Research Vagaries (Streiner DL) 68

mnemonics
Worry WARTS Have Generalized Anxiety Disorder [letter] (Coupland NJ) 197

moclobemide
Antidepressant Side Effects in Depression Patients Treated in A Naturalistic Setting: A Study of Bupropion, Moclobemide, Paroxetine, Sertraline, and Venlafaxine (Vanderkooy JD, Kennedy SH, Bagby RM) 174

mood
Selenium, Thyroid Hormones, Mood, and Behaviour [letter] (Sher L) 284

mood disorders
Mood Disorders—New Definitions, Treatment Directions, and Understandings [editorial] (Grof P) 123

Major Depression and Its Association With Long-Term Medical Conditions (Gagnon LM, Patten SB) 149

Seasonal Affective Disorders: Relevance of Icelandic and Icelandic-Canadian Evidence to Etiologic Hypotheses (Axelsson J, Stefánsson JG, Magnússon A, Sigvaldason H, Karlsson MM) 153

The Mood Disorder Questionnaire for Assessing Bipolar Spectrum Disorder Frequency [letter] (Benazzi F) 386

mood stabilizers
“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder (Ghaemi SN, Ko JY, Goodwin FK) 125

multiple sclerosis
Depression in Multiple Sclerosis Associated With Interferon Beta-1a (Rebif) [letter] (Pandya R, Patten S) 686

mutual maintenance
PTSD and the Experience of Pain: Research and Clinical Implications of Shared Vulnerability and Mutual Maintenance Models (Asmundson GJG, Coons MJ, Taylor S, Katz J) 930

N

N-acetylaspartate
Proton Magnetic Resonance Spectroscopy of the Hippocampus and Occipital White Matter in PTSD: Preliminary Results (Villarreal G, Petropoulos H, Hamilton DA, Rowland LM, Horan WP, Griego JA, Moreshead M, Hart BL, Brooks WM) 666

Native
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment (Wardman D, Khan N, el-Guebaly N) 355

naturalistic
Antidepressant Side Effects in Depression Patients Treated in A Naturalistic Setting: A Study of Bupropion, Moclobemide, Paroxetine, Sertraline, and Venlafaxine (Vanderkooy JD, Kennedy SH, Bagby RM) 174

nefazodone
Hepatic Adverse Reactions Associated With Nefazodone (Stewart DE) 375

negative symptoms
Understanding Predisposition to Schizophrenia: Toward Intervention and Prevention (Tsuang MT, Stone WS, Faraone SV) 518

neuroimaging
Imaging Brain Chemistry and Function in Neuropsychiatric Disorders [editorial] (Williamson PC) 313

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging (Grady CL, Keightley ML) 327

neuroleptic malignant syndrome
Quetiapine and Neuroleptic Malignant Syndrome [letter] (Solomons K) 791

A Case of Neuroleptic Malignant Syndrome With Clozapine and Risperidone [letter] (Beauchemin M-A, Millaud F, Nguyen KA) 886

neuropsychological deficits
Understanding Predisposition to Schizophrenia: Toward Intervention and Prevention (Tsuang MT, Stone WS, Faraone SV) 518

neuropsychology
Neuropsychological Performance in DSM-IV ADHD Subtypes: An Exploratory Study With Untreated Adolescents (Schmitz M, Cadore L, Paczko M, Kipper L, Chaves M, Rohde LA, Moura C, Knijnik M) 863

nor-clozapine
Relation of Blood Counts During Clozapine Treatment to Serum Concentrations of Clozapine and Nor-Clozapine (Oyewumi LK, Cernovsky ZZ, Freeman DJ, Streiner DL) 257

nosology
“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder (Ghaemi SN, Ko JY, Goodwin FK) 125

obesity
Topiramate Use in Obese Patients With Binge Eating Disorder: An Open Study (Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W) 271

obsessive–compulsive disorder
Association of QEEG Findings With Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction (Tot Ô, Özge A, Çömelekoglu Ü, Yazici K, Bal N) 538

Serum Cholesterol Level Comparison: Control Subjects, Anxiety Disorder Patients, and Obsessive–Compulsive Disorder Patients (Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M) 557

Are Leptin and Cytokines Involved in Body Weight Gain During Treatment With Antipsychotic Drugs? (Baptista T, Beaulieu S) 742

occupational stress
Occupational Effects of Stalking (Abrams KM, Robinson GE) 468

OCD
see obsessive–compulsive disorder

olanzapine
Olanzapine: A Proarrhythmic Drug? [letter] (Gupta N, Malhotra P) 683

olecranon bursitis
Olecranon Bursitis as a Complication of Tardive Dyskinesia [letter] (Patel S, Lal S) 687

Dissolution Profile, Tolerability, and Acceptability of the Orally Disintegrating Olanzapine Tablet in Patients With Schizophrenia (Chue P, Jones B, Taylor CC, Dickson R) 771

Olanzapine-Induced Hair Loss [letter] (Leung M, Wrixon K, Remick RA) 891

orally disintegrating tablet
Dissolution Profile, Tolerability, and Acceptability of the Orally Disintegrating Olanzapine Tablet in Patients With Schizophrenia (Chue P, Jones B, Taylor CC, Dickson R) 771

outcomes
Cognitive Therapy For Schizophrenia: From Conceptualization to Intervention (Rector NA, Beck AT) 39

Canadian Psychiatric Inpatient Religious Commitment: An Association With Mental Health (Baetz M, Larson DB, Marcoux G, Bowen R, Griffin R) 159

Psychological Treatments for Anorexia Nervosa: A Review of Published Studies and Promising New Directions (Kaplan AS) 235

outpatient treatment
A Test of the Phase Model of Psychotherapy Change (Joyce AS, Ogrodniczuk J, Piper WE, McCallum M) 759

oxcarbazepine
Oxcarbazepine Treatment of Posttraumatic Stress Disorder [letter] (Berigan T) 973

pain
PTSD and the Experience of Pain: Research and Clinical Implications of Shared Vulnerability and Mutual Maintenance Models (Asmundson GJG, Coons MJ, Taylor S, Katz J) 930

pain intensity
Sleep Quality in Chronic Pain Patients (Sayar K, Arikan M, Yontem T) 844

pain tolerance
Assessing Tolerance in a Patient With Acute Psychosis [letter] (Mujica R, Braunstein JW) 788

panic disorder
Serum Cholesterol Level Comparison: Control Subjects, Anxiety Disorder Patients, and Obsessive–Compulsive Disorder Patients (Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M) 557

panic attacks
Respiratory Symptoms in Nocturnal Panic Attacks [letter] (Lopes FL, Nascimento I, Valença AM, Versiani M, Nardi AE) 684

Carbon Dioxide Test in Respiratory Panic Disorder Subtype [letter] (Nardi AE, Valença AM, Nascimento I, Zin WA, Versiani M) 685

PANSS
see Positive and Negative Syndrome Scale

paroxetine
Antidepressant Side Effects in Depression Patients Treated in A Naturalistic Setting: A Study of Bupropion, Moclobemide, Paroxetine, Sertraline, and Venlafaxine (Vanderkooy JD, Kennedy SH, Bagby RM) 174

A Case of Paroxetine-Induced Galactorrhea [letter] (Davenport E, Velamoor R) 890

patient autonomy
Treatment Resistance in Anorexia Nervosa and the Pervasiveness of Ethics in Clinical Decision Making (MacDonald C) 267

patient transfer
The Ward Changes Address: An Entire Hospital Department Moves to a Modern Building [letter] (Melamed Y, Elizur A) 485

perfectionism
Re: Bilsbury and Others. More on the Phenomenology of Perfectionism—Incompleteness [letter] (Summerfeldt LJ, Antony MM, Swinson representative) 977

perpetrator
Homicide in the Canadian Prairies: Elderly and Nonelderly Killings (Ahmed AG, Menzies RPD) 875

personality disorder
Relation of Personality Disorders to Subtypes of Major Depression According Both to DSM-IV and ICD-10 [letter] (Iacovides A, Fountoulakis KN, Fotiou F, Fokas K, Nimatoudis I, Kaprinis G) 196

pharmaceutical companies
The Role of Pharmaceutical Companies in Research and Development—Plaudits and Cautions [editorial] (Rae-Grant Q) 513

pharmacologic treatment
Pharmacologic Treatment of Eating Disorders (Zhu AJ, Walsh BT) 227

pharmacotherapy
Breaking the Myths: New Treatment Approaches for Chronic Depression (Michalak EE, Lam RW) 635

phosphorus
In Vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders (Stanley JA) 315

politique de santé mentale
Réadaptation Psychiatrique en Milieu Francophone : Pratiques Actuelles, Défis Futurs (Tempier R, Favrod J) 621

polydrug use
Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study (Gross SR, Barrett SP, Shestowsky JS, Pihl RO) 546

Positive and Negative Syndrome Scale
Principal-Component Analysis of the Positive and Negative Syndrome Scale in Patients With Schizophrenia: Does a 5-Factor Model Apply to Published Data? [letter] (Canceil O, Sampaio-Meireles M, Poirier-Littre M-F, Bourdel M-C, Olie J-P, Attar-Levy D, Olivier V) 97

Beyond Principal-Component Analysis of the Positive and Negative Syndrome Scale in Patients With Schizophrenia [letter] (White L, Opler LA) 891

postgraduate education
Canadian Geriatric Psychiatrists: Why Do They Do It? A Delphi Study (Lieff S, Clarke D) 250

postpartum
Managing Bipolar Disorder During Pregnancy: Weighing the Risks and Benefits (Viguera AC, Baldessarini RJ, Cohen LS, Nonacs R) 426

posttraumatic stress
Posttraumatic Symptoms and Disability in Paramedics (Regehr C, Goldberg G, Glancy GD, Knott T) 953

posttraumatic stress disorder
Occupational Effects of Stalking (Abrams KM, Robinson GE) 468

Proton Magnetic Resonance Spectroscopy of the Hippocampus and Occipital White Matter in PTSD: Preliminary Results (Villarreal G, Petropoulos H, Hamilton DA, Rowland LM, Horan WP, Griego JA, Moreshead M, Hart BL, Brooks WM) 666

Treatment Of Posttraumatic Stress Disorder With Tiagabine [letter] (Berigan T) 788

Epidemiologic Studies of Trauma, Posttraumatic Stress Disorder, and Other Psychiatric Disorders (Breslau N) 923

PTSD and the Experience of Pain: Research and Clinical Implications of Shared Vulnerability and Mutual Maintenance Models (Asmundson GJG, Coons MJ, Taylor S, Katz J) 930

Oxcarbazepine Treatment of Posttraumatic Stress Disorder [letter] (Berigan T) 973

power
Breaking Up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data (Streiner DL) 262

practice
Canadian Geriatric Psychiatrists: Why Do They Do It? A Delphi Study (Lieff S, Clarke D) 250

practice guidelines
The Role of Estrogen in Schizophrenia: Implications for Schizophrenia Practice Guidelines for Women (Grigoriadis S, Seeman MV) 437

pregnancy
Managing Bipolar Disorder During Pregnancy: Weighing the Risks and Benefits (Viguera AC, Baldessarini RJ, Cohen LS, Nonacs R) 426

Antipsychotic Medication During Pregnancy and Lactation in Women With Schizophrenia: Evaluating the Risk (Patton SW, Misri S, Corral MR, Perry KF, Kuan AJ) 959

premenstrual dysphoric disorder
Distress Levels in Patients With Premenstrual Dysphoric Disorder [letter] (Kuan AJ, Carter DMG, Ott FJ) 888

premorbid
Preventing Schizophrenia and Psychotic Behaviour: Definitions and Methodological Issues (Faraone SV, Hendricks Brown C, Glatt SJ, Tsuang MT) 527

prescription medication
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment (Wardman D, Khan N, el-Guebaly N) 355

prescription privileges
Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists (Lavoie KL, Fleet RP) 443

prétest
La traduction des questionnaires et des tests : techniques et problèmes (Massoubre C, Lang F, Jaeger B, Jullien M, Pellet J) 61

prevalence
Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario (Bradley EA, Thompson A, Bryson SE) 652

Prevalence and Incidence Studies of Schizophrenic Disorders: A Systematic Review of the Literature (Goldner EM, Hsu L, Waraich P, Somers JM) 833

prevalence estimates
The National Survey of Mental Health and Well-Being in Australia: Impact on Policy (Henderson S) 819

prevalence rates
The Impact of Latitude on the Prevalence of Seasonal Depression (Levitt AJ, Boyle MH) 361

prevention
Preventing Schizophrenia and Psychotic Behaviour: Definitions and Methodological Issues (Faraone SV, Hendricks Brown C, Glatt SJ, Tsuang MT) 527

primary care
Brief Screening Tests for Dementia (Lorentz WJ, Scanlan JM, Borson S) 723

Strategies of Collaboration Between General Practitioners and Psychiatrists: A Survey of Practitioners’ Opinions and Characteristics (Lucena RJM, Lesage A, Élie R, Lamontagne Y, Corbière M) 750

Counsellors in Primary Care: Benefits and Lessons Learned (Kates N, Crustolo A-M, Farrar S, Nikolaou L) 857

prodrome
Preventing Schizophrenia and Psychotic Behaviour: Definitions and Methodological Issues (Faraone SV, Hendricks Brown C, Glatt SJ, Tsuang MT) 527

prognosis
A Follow-Up Study of Patients With DSM-IV Schizophreniform Disorder (Iancu I, Dannon PN, Ziv R, Lepkifker E) 56

prosopagnosia
Capgras Syndrome and Blindness: Against the Prosopagnosia Hypothesis [letter] (Dalgalarrondo P, Fujisawa G, Banzato CEM) 387

proton
In Vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders (Stanley JA) 315

psychiatric learners
Perceptions of Intimidation in the Psychiatric Educational Environment in Edmonton, Alberta (Tibbo P, de Gara CJ, Blake TM, Steinberg C, Stonehocker B) 562

psychiatric disorders
Psychiatric Disorders and Use of Mental Health Services by Ontario Women (Frise S, Steingart A, Sloan M, Cotterchio M, Kreiger K) 849

psychiatric epidemiology
Psychiatric Epidemiology: Vibrant Art and Penetrating Science [editorial] (Goldner EM) 817

The National Survey of Mental Health and Well-Being in Australia: Impact on Policy (Henderson S) 819

psychology
Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists (Lavoie KL, Fleet RP) 443

psychopharmacology
Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists (Lavoie KL, Fleet RP) 443

psychoses
The National Survey of Mental Health and Well-Being in Australia: Impact on Policy (Henderson S) 819

psychosis
Managing Bipolar Disorder During Pregnancy: Weighing the Risks and Benefits (Viguera AC, Baldessarini RJ, Cohen LS, Nonacs R) 426

Using the Rating Scale for Psychotic Symptoms to Characterize Delusions Expressed in a Schizophrenia Patient With “Internet Psychosis” [letter] (Margolese HC, Chouinard G, Beauclair L, Miller M) 485

Psychotic Mania in Bipolar II Depression Related to Sertraline Discontinuation [letter] (Benazzi F) 584

Assessing Pain Tolerance in a Patient With Acute Psychosis [letter] (Mujic